Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Predictive Oncology Inc (POAI)

Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Predictive Oncology Inc 91 43RD STREET SUITE 110 PITTSBURGH PA 15201 USA

https://predictive-oncology.com Employees: 35 P: 412-432-1500

Description:

Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.

Key Statistics

Overview:

Market Capitalization, $K 4,974
Enterprise Value, $K -3,756
Shares Outstanding, K 6,667
Annual Sales, $ 1,780 K
Annual Net Income, $ -13,980 K
Last Quarter Sales, $ 350 K
Last Quarter Net Income, $ -3,090 K
EBIT, $ -13,250 K
EBITDA, $ -12,510 K
60-Month Beta 1.19
% of Insider Shareholders 3.44%
% of Institutional Shareholders 9.04%
Float, K 6,438
% Float 96.56%
Short Volume Ratio 0.57

Growth:

1-Year Return -73.97%
3-Year Return -96.08%
5-Year Return -98.40%
5-Year Revenue Growth 26.24%
5-Year Earnings Growth 97.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -2.93
EPS Growth vs. Prev Qtr 47.06%
EPS Growth vs. Prev Year 53.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 04/24/23

POAI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -286.30%
Return-on-Assets % -122.11%
Profit Margin % -785.39%
Debt/Equity 0.00
Price/Sales 2.57
Price/Cash Flow N/A
Price/Book 2.33
Book Value/Share 0.30
Interest Coverage -0.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar